Vitamin A is linked to the expression of the AI-CIII-AIV gene cluster in familial combined hyperlipidemia

Journal of Lipid Research

Volumn 40, Issue 3, 1999, Pages 426-431

  Ribalta, Josep ^a   Girona, Josefa ^a   Vallvé, Joan C ^a   La Ville, Agnes E ^a   Heras, Mercedes ^a   Masana, Lluís ^a  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

Author keywords

Fibrates; HyperapoB; Peroxisome proliferator activated receptor; Retinoic acid; Retinoid X receptor; Syndrome X

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN C3; RETINOL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DNA DETERMINATION; DNA POLYMORPHISM; FAMILIAL HYPERLIPEMIA; FAMILY STUDY; FEMALE; GENE CLUSTER; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC ASSOCIATION; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL;

ADULT; APOLIPOPROTEIN A-II; APOLIPOPROTEIN C-III; APOLIPOPROTEINS A; APOLIPOPROTEINS C; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; MALE; MULTIGENE FAMILY; POLYMORPHISM, GENETIC; VITAMIN A;

EID: 0033041658     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Rose, H. G., P. Kranz, M. Weinstock, J. Juliano, and J. I. Haft. 1973. Inheritance of combined hyperlipoproteinemia: evidence for a new lipoprotein phenotype. Am. J. Med. 54: 148-160.
2. Goldstein, J. L., H. G. Schrott, W. R. Hazzard, E. L. Bierman, and A. G. Motulsky. 1973. Hyperlipidaemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J. Clin. Invest. 52: 1544-1568.
3. Nikkilä, E. A., and A. Aro. 1973. Family study of serum lipids and lipoproteins in coronary heart disease. Lancet. 1: 954-959.
4. Kwiterovich, P. O., Jr., S. White, T. Forte, P. S. Bachoricik, H. Smith, and A. Sniderman. 1987. Hyperapobetalipoproteinemia in a kindred with familial combined hyperlipidemia and familial hypercholesterolemia. Arteriosclerosis. 7: 211-225.
5. Sniderman, A., B. G. Brown, B. F. Stewart, and K. Cianflone. 1992. From familial combined hyperlipidemia to hyperapoB: unravelling the overproduction of hepatic apolipoprotein B. Curr. Opin. Lipidol. 3: 137-142.
6. Brunzell, J. D., J. J. Albers, A. Chait, S. M. Grundy, E. Groszek, and G. B. McDonald. 1983. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. J. Lipid Res. 24: 147-155.
7. Babirak, S. P., G. Brown, and J. D. Brunzell. 1992. Familial combined hyperlipidemia and abnormal lipoprotein lipase. Arterioscler. Thromb. 12: 1176-1183.
8. Reaven, G. M. 1988. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 37: 1595-1607.
9. Hunt, S. C., L. L. Wu, P. N. Hopkins, B. M. Stults, H. Kuida, M. E. Ramirez, J. M. Lalouel, and R. R. Williams. 1989. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia (Study of Utah patients with familial dyslipidemic hypertension). Arteriosclerosis. 9: 335-344.
10. Dallinga-Thie, G. M., X. D. Bu, M. v L-S. Trip, J. I. Rotter, A. J. Lusis, and T. W. A. de Bruin. 1996. Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: effects on LDL-cholesterol and apolipoproteins B and C-III. J. Lipid Res. 37: 136-147.
11. Ribalta, J., A. E. La Ville, J. C. Vallvé, S. Humphries, P. R. Turner, and L. Masana. 1997. A variation in the apolipoprotein C-III gene is associated with an increased number of circulating VLDL and IDL particles in familial combined hyperlipidemia. J. Lipid Res. 38: 1061-1069.
12. Dallinga-Thie, G. M., M. v L-S. Trip, J. I. Rotter, R. M. Cantor, X. D. Bu, A. J. Lusis, and T. W. A. de Bruin. 1997. Complex genetic contribution of the AI-CIII-AIV gene cluster to familial combined hyperlipidemia. J. Clin. Invest. 99: 953-961.
13. Castro Cabezas, M., T. W. A. de Bruin, H. Jansen, A. W. Kock, W. Kortlandt, and D. W. Erkelens. 1993. Impaired chylomicron remnant clearance in Familial Combined Hyperlipidemia. Arterioscler. Thromb. 13: 804-814.
14. Nagasaki, A., T. Kikuchi, K. Kurata, S. Masushige, T. Hasegawa, and S. Kato. 1994. Vitamin A regulates the expression of the apolipoprotein AI and CIII genes in the rat. Biochem. Biophys. Res. Commun. 205: 1510-1571.
15. Zolfaghari, R., and A. C. Ross. 1994. Effect of vitamin A deficiency and retinoic acid repletion on intestinal and hepatic apolipoprotein A-I mRNA levels of adult rats. J. Lipid Res. 35: 1985-1992.
16. Auwerx, J., K. Schoonjans, J. C. Fruchart, and B. Staels. 1996. Transcriptional control of triglyceride metabolism: fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPAR. Atherosclerosis. 124: S29-S37.
17. Schoonjans, K., B. Staels, and J. Auwerx. 1996. The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation. Biochim. Biophys. Acta. 1302: 93-109.
18. Ribalta, J., A. E. La Ville, J. Girona, J. C. Vallvé, and L. Masana. 1997. Low plasma vitamin A concentrations in familial combined hyperlipidemia. Clin. Chem. 43: 2379-2383.
19. Xu, C. F., P. Talmud, H. Schuster, R. Houlston, G. Miller, and S. Humphries. 1994. Association between genetic variation at the APO AI-CIII-AIV gene cluster and familial combined hyperlipidemia. Clin. Genet. 46: 385-397.
20. Wojciechowski, A. P., M. Farrall, P. Cullen, T. M. E. Wilson, J. D. Bayliss, B. Farren, B. A. Griffin, M. J. Caslake, C. J. Packard, J. Shepherd, R. Thakker, and J. Scott. 1991. Familial combined hyperlipidemia linked to the apolipoprotein AI-CIII-AIV gene cluster on chromosome 11q23-q24. Nature. 249: 161-164.
21. Sigurdsson, G., Jr., V. Gudnason, G. Sigurdsson, and S. E. Humphries. 1992. Interaction between a polymorphism of the apo A-I promoter region and smoking determines plasma levels of HDL and apo A-I. Arterioscler. Thromb. 12: 1017-1022.
22. Schumaker, V. R., and D. L. Puppione. 1986. Sequential flotation ultracentrifugation. Methods Enzymol. 128: 155-170.
23. Bieri, J. C., T. J. Tolliver, and G. L. Catignani. 1979. Simultaneous determination of alpha-tocopherol and retinol in plasma or red cells by high pressure liquid chromatography. Am. J. Clin. Nutr. 10: 2143-2149.
24. Miller, S. A., D. D. Dykes, and H. F. Polesky. 1988. A simple salting out method procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16: 1215.
25. Xu, C. F., P. Talmud, and S. E. Humphries. 1994. Three new polymorphisms of the apoAI-CIII-AIV gene cluster. Mol. Cell. Probes. 8: 331-332.
26. Xu, C. F., F. Angelico, M. Del Ben, and S. Humphries. 1993. Role of genetic variation at the apo AI-CIII-AIV gene cluster in determining plasma apo AI levels in boys and girls. Genet. Epidemiol. 10: 113-122.
27. Mukherjee, R., J. Strasse, L. Jow, P. Hoener, J. R. Paterniti, Jr., and R. A. Heyman. 1998. RXR agonists activate PPARα-inducible genes, lower triglycerides, and raise HDL levels in vivo. Arterioscler. Thromb. Vasc. Biol. 18: 272-276.